This mutation reduces the promoter activity of LIMK1 and a consequent decrease in LIMK1 protein levels, leading to the malformation of cerebral blood vessels and an increased incidence of intracranial aneurysms (Akagawa et al., 2006). The gene discussed is LIMK1; the disease is Dilatation of the cerebral artery.